Long-Term Outcomes of Neonatal Abstinence Syndrome:
Implications for Providers and Caregivers
October 29, 2018 – 2:30 p.m. EDT
Michael Warren, MD, MPH, FAAP
Associate Administrator, Maternal and Child Health Bureau, Health Resources and Services Administration
Mary-Margaret A. Fill, MD
Mary-Margaret A. Fill, MD Medical Epidemiologist, Tennessee Department of Health
Coleen Boyle, PhD, MS hyg
Director, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention
Lisa F. Wadell, MD
SVP, Maternal and Child Health Impact/NICU Innovation, Interim Chief Medical Officer, March of Dimes
This webcast is approved for up to 1.0 Continuing Medical Education credits prescribed by The American Academy of Family Physicians (AAFP). All continuing education credits are provided free of charge.
Learn about the epidemiology, clinical presentation, treatment and long-term outcomes of infants with neonatal abstinence syndrome (NAS) in the U.S. Opportunities for prevention and early intervention will be discussed.
1. Discuss CDC’s role in protecting mothers and babies in the context of the opioid epidemic.
2. Review the clinical presentation and treatment options for infants with NAS.
3. Discuss possible long-term outcomes of NAS.
4. Outline opportunities for prevention or early intervention in children and families at risk for NAS.
Post a Comment